5-((3-(4-Butoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(2-ethylhexyl)-2-thioxothiazolidin-4-one

Catalog No. :
ACQXOB699
CAS No. :
378757-85-8
Molecular Formula :
C31H37N3O2S2
Molecular Weight :
547.79

IUPAC Name:(Z)-5-((3-(4-butoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(2-ethylhexyl)-2-thioxothiazolidin-4-one

5-((3-(4-Butoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(2-ethylhexyl)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-(4-Butoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(2-ethylhexyl)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((3-(4-butoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(2-ethylhexyl)-2-thioxothiazolidin-4-one
MDL No.MFCD02986199
Molecular FormulaC31H37N3O2S2
Molecular Weight547.79
SMILESO=C1N(CC(CC)CCCC)C(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(OCCCC)C=C4)=S
InChI KeyBWTWDAIKKYFIGN-RRAHZORUSA-N
SynonymSALOR-INT L433624-1EA;(5Z)-5-([3-(4-BUTOXYPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-3-(2-ETHYLHEXYL)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[[3-(4-butoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-3-(2-ethylhexyl)-2-thioxo-
CAS No.378757-85-8

Synthetic Route by SureRoute

1. ACQXOB699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXOB699 route product structure diagram
    ACQXOB699378757-85-8
Inquiry

2. ACQXOB699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOZEC674 route compound structure diagram
    ACOZEC67418908-66-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXOB699 route product structure diagram
    ACQXOB699378757-85-8
Inquiry

Comments (0)